ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

リコンビナントタンパク質

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
CAA-L5149
製品名称
NLS-Cas12a Nuclease (MALS verified)
タンパク質名
Cas12a
Species
Lachnospiraceae bacterium
HOST
E. coli
50ug: 28000円
お問い合わせ
100ug: 61600円
お問い合わせ
500ug: 229600円
お問い合わせ

Overview

Synonyms -
Characteristics The protein has a calculated MW of 147.6 kDa. The protein migrates as 130-140 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE). This protein has two NLS, which leads to transport to the nucleus efficiently. It is ideal for in vitro and in vivo reactions.
Endotoxin Level 0.01 EU per μg
Purity 95%
Description Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated endonuclease from Lachnospiraceae bacterium,Cas12a, also known as Cpf1, is a 1200-1500 amino-acids long monomeric protein that belongs to the CRISPR/Cas system , an adaptive immune system of prokaryotes that has now become a powerful tool for genome editing. CRISPR/Cas12a belongs the class II (type 5) of the CRISPR/Cas system that is defined by a single-subunit effector. Cas12a has recently emerged as an alternative for Cas9, due to its distinct features such as the ability to target T-rich motifs, no need for trans-activating crRNA, inducing a staggered double-strand break and potential for both RNA processing and DNA nuclease activity. In addition, Cas12a is able to process more structured pre-CRISPR/RNA(crRNA) molecules into mature crRNAs which allows the possibility to use both mature or pre-crRNA for genome editing purposes. All these features make the CRISPR/Cas12a system a valuable genome-engineering tool. CRISPR-Cas12a has been successfully used to edit genomes in many mammalians cells and plants.
Reference -
URL https://www.acrobiosystems.com/P4818-NLS-Cas12a-Nuclease-%28MALS-verified%29.html

お問い合わせリスト(-)

お問い合わせフォーム